Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - propofol 10 mg/ml - emulsion for injection/infusion - 10 mg/ml - propofol 10 mg/ml - propofol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - propofol 10 mg/ml - emulsion for injection/infusion - 10 mg/ml - propofol 10 mg/ml - propofol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - propofol 10 mg/ml - emulsion for injection/infusion - 10 mg/ml - propofol 10 mg/ml - propofol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - propofol 20 mg/ml - emulsion for injection/infusion - 20 mg/ml - propofol 20 mg/ml - propofol

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol injectable emulsion is an iv general anesthetic and sedation drug that can be used as described in the table below. table 3. indications for propofol injectable emulsion safety, effectiveness and dosing guidelines for propofol injectable emulsion have not been established for mac sedation in the pediatric population; therefore, it is not recommended for this use (see precautions, pediatric use). propofol injectable emulsion is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations. in the intensive care unit (icu), propofol injectable emulsion can be administered to intubated, mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management. propofol injectable emuls

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol injectable emulsion is an iv general anesthetic and sedation drug that can be used as described in the table below. table 3. indications for propofol injectable emulsion safety, effectiveness and dosing guidelines for propofol injectable emulsion have not been established for mac sedation in the pediatric population; therefore, it is not recommended for this use (see precautions, pediatric use). propofol injectable emulsion is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations. in the intensive care unit (icu), propofol injectable emulsion can be administered to intubated, mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management. propofol injectable emuls

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc. - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol injectable emulsion is an iv general anesthetic and sedation drug that can be used as described in the table below. safety, effectiveness and dosing guidelines for propofol injectable emulsion have not been established for mac sedation in the pediatric population; therefore, it is not recommended for this use (see precautions , pediatric use ). propofol injectable emulsion is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations. in the intensive care unit (icu), propofol injectable emulsion can be administered to intubated, mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management. propofol injectable emulsion is not indicated for use in pediatric icu sedation

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol injectable emulsion is an intravenous general anesthetic and sedation drug indicated for: - induction of general anesthesia for patients greater than or equal to 3 years of age - maintenance of general anesthesia for patients greater than or equal to 2 months of age - initiation and maintenance of monitored anesthesia care (mac) sedation in adult patients - sedation for adult patients in combination with regional anesthesia - intensive care unit (icu) sedation of intubated, mechanically ventilated adult patients limitations of use propofol is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations [see pediatric use (8.4)] . safety, effectiveness and dosing guidelines for propofol have not been established for mac sedation in the pediatric population; therefore, it is not recommended for this use [see pediatric use (8.4)]. propofol is not indicate

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol injectable emulsion is an intravenous general anesthetic and sedation drug indicated for: limitations of use propofol injectable emulsion is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations [see pediatric use (8.4)] . safety, effectiveness and dosing guidelines for propofol injectable emulsion have not been established for mac sedation in the pediatric population; therefore, it is not recommended for this use [see pediatric use (8.4)] . propofol injectable emulsion is not indicated for use in pediatric icu sedation since the safety of this regimen has not been established [see pediatric use (8.4)] . propofol injectable emulsion is contraindicated in patients with a known hypersensitivity to propofol or any of propofol injectable emulsion components. propofol injectable emulsion is contraindicated in patients with a history of anaphylaxis to

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol injectable emulsion is an anesthetic injection for use in dogs and cats as follows: 1. as a single injection to provide general anesthesia for short procedures. 2. for induction and maintenance of general anesthesia using incremental doses to effect. 3. for induction of general anesthesia where maintenance is provided by inhalant anesthetics. induction of general anesthesia will usually be observed within 30 to 60 seconds after the end of administration (administration should take 60 to 90 seconds). the doses for induction and maintenance vary depending upon species and preanesthetics. the duration of anesthesia varies depending upon species, dose, and preanesthetics. in dogs, the duration of anesthesia following the recommended induction dose (5.5 to 7.0 mg/kg without premedication) is generally 5 to 7 minutes. the duration of anesthesia after maintenance doses varies from 2 to 6 minutes following 1.1 mg/kg to 6 to 10 minutes following 3.3 mg/kg. full standing recovery is generally observed within 10 to 20 minutes after the end of anesthesia, regardless of the duration of anesthesia. recovery may be delayed in sighthounds or if preanesthetics are administered. in cats, the duration of anesthesia following the recommended induction dose (8.0 to 13.2 mg/kg without premedication) is generally 5 to 12 minutes. the duration of anesthesia after maintenance doses varies from 5 to 7 minutes following 1.1 mg/kg to 12 to 18 minutes following 4.4 mg/kg. full standing recovery is generally observed within 30 to 45 minutes after the end of anesthesia, regardless of the duration of anesthesia. recovery may be delayed if preanesthetics are administered. propofol injectable emulsion injection is contraindicated in dogs and cats with a known hypersensitivity to propofol or its components, or when general anesthesia or sedation are contraindicated. not for human use. keep out of reach of children. propofol injectable emulsion injection should be managed to prevent the risk of diversion, through such measures as restriction of access and the use of drug accountability procedures appropriate to the clinical setting. rare cases of self-administration of propofol have been reported, including dose-related fatalities. preventive care should be taken to avoid self-administration; for example, use of a guarded needle until the moment of injection is recommended. symptoms of self-administration may include cardiovascular and/or respiratory depression. anaphylaxis to propofol may occur during its first use, especially in patients with a history of drug allergy.7 in the event of accidental self-administration, seek medical attention immediately. contact of this product with skin, eyes, and clothes should be avoided. if contact occurs, skin and eyes should be liberally flushed with water for 15 minutes. if irritation develops and continues, consult a physician. initial arousal following propofol anesthesia can be extremely rapid. caution should be used at this time in manipulations involving the mouth, such as removing an endotracheal tube.